Brief: Galmed Pharma Provides Additional Positive Data From The Open Label Part Of ARMOR Study And Reports Q3 2021 Financial Results

Eocene

08/11/2021 12:46

Nov 8 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED PHARMACEUTICALS PROVIDES ADDITIONAL POSITIVE DATA
FROM
THE OPEN LABEL PART OF ARMOR STUDY AND REPORTS THIRD QUARTER
2021 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.31
    * QTRLY CASH AND CASH EQUIVALENTS $42.0 MILLION VERSUS $50.9
MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.36 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn6mvs4Ba 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;;))